ISSN: 2155-9899
Camille Locht
Institut Pasteur de Lille, Centre d’Infection et d’Immunité de Lille, Lille, France
Dr Camille Locht holds currently a position as Research Director at the French National Institute of Health and Medical Research (Inserm) and heads the Center for Infection and Immunity of Lille on the campus of the Institut Pasteur de Lille in France. He has obtained his PhD at the Catholic University of Leuven in Belgium in 1984. After a 3-years post-doctoral stay at the National Institute of Allergy and Infectious Disease in the USA, where he started to work on pertussis and cloned the pertussis toxin genes, he joined SmithKline – Beecham (now GSK) to help developing acellular pertussis vaccines. Since 1989 he is the head of a research laboratory at the Institut Pasteur de Lille, where he has been the Scientific Director from 2005 to 2013.
Clinical Immunology, Cellular Immunology, Adaptive Immunity,Vaccines and Immunity for Newborns,Tuberculosis Meningitis,Dendrite Cell Biology